The biopharmaceutical processing equipment & consumables market is witnessing robust growth, driven by the rising production of biologics, biosimilars, vaccines, and advanced cell and gene therapies. Increasing investments in biopharmaceutical manufacturing capacity, coupled with the widespread adoption of single-use technologies and automation, are accelerating market expansion.

生物制药加工设备与耗材市场正经历强劲增长，这得益于生物制品、生物类似药、疫苗以及先进细胞和基因疗法产量的不断上升。对生物制药制造产能投资的增加，加上一次性技术和自动化的广泛采用，正在加速市场扩张。

Growing demand for high-quality, scalable, and regulatory-compliant manufacturing solutions is further fueling the adoption of advanced processing equipment and consumables..

对高质量、可扩展且符合法规要求的制造解决方案的需求不断增长，进一步推动了先进加工设备和耗材的采用。

LAS VEGAS

拉斯维加斯

,

，

July 7, 2026

2026年7月7日

/PRNewswire/ -- DelveInsight's Biopharmaceutical Processing Equipment & Consumables Market Insights report provides the current and forecast market analysis, individual leading biopharmaceutical processing equipment & consumables companies' market shares, challenges, biopharmaceutical processing equipment & consumables market drivers, barriers, trends, and key biopharmaceutical processing equipment & consumables companies in the market..

/美通社/ -- DelveInsight发布的《生物制药加工设备与耗材市场洞察》报告提供了当前及预测性的市场分析、各领先生物制药加工设备与耗材公司的市场份额、挑战、生物制药加工设备与耗材市场的驱动因素、壁垒、趋势，以及市场上的关键生物制药加工设备与耗材公司。

Biopharmaceutical Processing Equipment & Consumables Market Summary

生物制药加工设备与耗材市场综述

2025 Biopharmaceutical Processing Equipment & Consumables Market Size:

2025年生物制药加工设备与耗材市场规模：

USD 52.1 Billion

521亿美元

2034 Projected Biopharmaceutical Processing Equipment & Consumables Market Size:

2034年生物制药加工设备与耗材预计市场规模：

USD 116.4 Billion

1164亿美元

Biopharmaceutical Processing Equipment & Consumables Market Growth Rate (2026-2034): ~

生物制药加工设备与耗材市场增长率（2026-2034年）：~

9%

9%

Largest Biopharmaceutical Processing Equipment & Consumables Market:

最大的生物制药加工设备与耗材市场：

North America

北美洲

Largest Product Type Segment:

最大产品类型细分市场：

Filtration Systems Category

过滤系统类别

Key Companies in the Biopharmaceutical Processing Equipment & Consumables Market:

生物制药工艺设备与耗材市场的主要企业：

Thermo Fisher Scientific Inc., Sartorius AG, Cytiva, Merck KGaA, Eppendorf SE, Lonza Group AG, Repligen Corporation, Avantor, Inc., Corning Incorporated, Danaher Corporation, Getinge AB, GEA Group AG, ABEC, Inc., PBS Biotech, Inc., Meissner Filtration Products, Inc., Entegris, Inc., Saint-Gobain Life Sciences, Parker-Hannifin Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and others.

赛默飞世尔科技公司、 Sartorius AG、Cytiva、默克集团、艾本德公司、龙沙集团、Repligen Corporation、Avantor, Inc.、康宁公司、丹纳赫公司、Getinge AB、GEA 集团、ABEC, Inc.、PBS Biotech, Inc.、Meissner Filtration Products, Inc.、Entegris, Inc.、圣戈班生命科学、派克汉尼汾公司、安捷伦科技公司、伯乐实验室公司，以及其他公司。

To read more about the latest highlights related to the biopharmaceutical processing equipment & consumables market, get a snapshot of the key highlights @

如需了解更多关于生物制药加工设备与耗材市场的最新亮点，请查看关键亮点概览 @

https://www.delveinsight.com/report-store/biopharmaceutical-processing-equipment-and-consumables-market

https://www.delveinsight.com/report-store/biopharmaceutical-processing-equipment-and-consumables-market

Key Factors Contributing to the Rise in Growth of the Biopharmaceutical Processing Equipment & Consumables Market

推动生物制药加工设备与耗材市场增长的关键因素

Rising Demand for Biologics and Biosimilars:

生物制剂和生物类似药的需求不断增长：

The increasing adoption of monoclonal antibodies, vaccines, recombinant proteins, cell therapies, and biosimilars has significantly boosted the need for advanced biopharmaceutical processing equipment and single-use consumables. These products require specialized manufacturing systems to ensure high product quality and regulatory compliance..

单克隆抗体、疫苗、重组蛋白、细胞疗法和生物类似药的日益普及，显著推动了对先进生物制药加工设备和一次性耗材的需求。这些产品需要专门的制造系统，以确保高质量的产品和符合监管要求。

Expansion of Biopharmaceutical Manufacturing Capacity:

生物制药生产能力的扩张：

Pharmaceutical companies and contract manufacturers are investing heavily in expanding production facilities to meet the growing global demand for biologics. These capacity expansions are driving purchases of bioreactors, filtration systems, chromatography equipment, and disposable processing components..

制药公司和合同制造商正在大力投资扩大生产设施，以满足全球对生物制品日益增长的需求。这些产能扩张正推动着生物反应器、过滤系统、色谱设备以及一次性加工组件的采购。

Growing Adoption of Single-Use Technologies:

一次性技术的日益普及：

Single-use bioprocessing equipment and consumables are increasingly replacing traditional stainless-steel systems due to their lower contamination risk, reduced cleaning requirements, faster turnaround times, and lower operational costs. This trend is accelerating market growth across both clinical and commercial manufacturing..

一次性生物加工设备与耗材正日益取代传统的不锈钢系统，这得益于其更低的污染风险、更少的清洁需求、更快的周转时间以及更低的运营成本。这一趋势正在加速临床和商业制造领域的市场增长。

Increasing Investments in Cell and Gene Therapy Production:

增加对细胞和基因治疗生产的投资：

The rapid development of cell and gene therapies has created demand for specialized processing equipment capable of handling small-batch, high-value biologics. Manufacturers are investing in flexible and scalable technologies to support these advanced therapeutic modalities.

细胞和基因疗法的快速发展催生了对能够处理小批量、高价值生物制品的专用加工设备的需求。制造商正在投资灵活且可扩展的技术，以支持这些先进的治疗方式。

Expansion of CDMOs:

CDMO的扩张：

The growing reliance on outsourcing biopharmaceutical manufacturing has fueled investments by CDMOs in state-of-the-art processing infrastructure. Their continuous expansion is driving sustained demand for bioprocess equipment, consumables, and automation solutions.

对生物制药外包生产日益增长的依赖，推动了合同研发生产组织（CDMO）对先进加工基础设施的投资。其持续扩张正带动对生物工艺设备、耗材及自动化解决方案的持续需求。

Technological Advancements in Bioprocessing:

生物加工技术的技术进步：

Innovations such as automated bioreactors, continuous bioprocessing, digital monitoring systems, process analytical technologies (PAT), and AI-enabled manufacturing are improving production efficiency, product consistency, and operational flexibility, encouraging equipment upgrades.

自动化生物反应器、连续生物加工、数字监控系统、过程分析技术（PAT）以及人工智能赋能的制造等创新，正在提高生产效率、产品一致性和操作灵活性，从而推动设备升级。

Increasing Vaccine Production and Pandemic Preparedness:

增加疫苗生产和大流行准备：

Governments and pharmaceutical companies continue to strengthen vaccine manufacturing capabilities to improve preparedness for future infectious disease outbreaks. This has resulted in ongoing investments in upstream and downstream bioprocessing equipment and disposable consumables.

各国政府和制药公司持续加强疫苗生产能力，以提升对未来传染病暴发的应对准备。这促使上游和下游生物加工设备以及一次性耗材领域的投资持续增长。

Stringent Regulatory and Quality Standards:

严格的监管与质量标准：

Regulatory agencies require strict compliance with Good Manufacturing Practices (GMP) and quality assurance protocols for biologics manufacturing. This encourages manufacturers to adopt advanced processing systems and high-quality consumables that enhance process reliability and product safety.

监管机构要求生物制品生产严格遵守良好生产规范（GMP）和质量保证协议。这促使制造商采用先进的处理系统和高质量耗材，以提高工艺可靠性和产品安全性。

Growing Biopharmaceutical R&D Activities:

不断增长的生物制药研发活动：

Rising research investments by pharmaceutical companies, biotechnology firms, and academic institutions are increasing the demand for laboratory-scale and pilot-scale bioprocessing equipment. The transition of drug candidates from research to commercial manufacturing further supports market expansion..

制药公司、生物技术公司和学术机构不断上升的研究投资正在增加对实验室规模和中试规模生物加工设备的需求。候选药物从研究阶段向商业化生产阶段的过渡进一步推动了市场扩张。

Get a sneak peek at the biopharmaceutical processing equipment & consumables market dynamics @

抢先了解生物制药加工设备与耗材市场的动态 @

Biopharmaceutical Processing Equipment & Consumables Market Trends

生物制药加工设备与耗材市场趋势

Regional Biopharmaceutical Processing Equipment & Consumables Market Insights

区域生物制药加工设备与耗材市场洞察

North America

北美

North America held the largest share of the biopharmaceutical processing equipment & consumables market, accounting for approximately 38% of global revenue in 2025.

北美在生物制药加工设备与耗材市场中占据最大份额，2025年约占全球收入的38%。

The region's leadership is supported by its well-established biopharmaceutical industry, robust manufacturing capabilities, and continuous investments in biologics research, development, and production.

该地区的领导地位得益于其成熟的生物制药产业、强大的制造能力，以及对生物制品研发与生产的持续投资。

The United States, in particular, is home to a large number of biopharmaceutical and biotechnology companies, which represent the primary consumers of bioprocessing equipment and consumables for both clinical development and commercial manufacturing.

尤其是美国，拥有大量生物制药和生物技术公司，这些公司是临床开发和商业化生产中生物加工设备与耗材的主要消费者。

Furthermore, favorable government initiatives promoting biotechnology and biomanufacturing, coupled with the growing demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies, are accelerating the expansion of manufacturing capacity across the region.

此外，政府推动生物技术和生物制造的有利举措，加之对包括单克隆抗体、疫苗以及细胞和基因疗法在内的生物制品需求不断增长，正在加速该地区制造能力的扩张。

The increasing adoption of advanced technologies such as single-use bioprocessing systems, process automation, and digital manufacturing solutions is further enhancing production efficiency and flexibility.

一次性生物工艺系统、过程自动化和数字化制造解决方案等先进技术的日益普及，正在进一步提升生产效率和灵活性。

In addition, North America's mature supply chain infrastructure, highly skilled workforce, and strong focus on technological innovation continue to reinforce its dominant position in the global biopharmaceutical processing equipment & consumables market.

此外，北美成熟的供应链基础设施、高素质的劳动力队伍以及对技术创新的高度重视，继续巩固其在全球生物制药加工设备及耗材市场的主导地位。

Europe

欧洲

The European biopharmaceutical processing equipment and consumables market is experiencing steady growth, supported by the region's well-established biopharmaceutical manufacturing industry, rising investments in biologics production, and a favorable regulatory and innovation landscape.

欧洲生物制药加工设备与耗材市场正经历稳步增长，这得益于该地区成熟的生物制药制造产业、对生物制品生产投资的不断增加，以及有利的监管和创新环境。

Europe hosts several prominent bioprocessing technology providers, including Sartorius AG and Cytiva, alongside a strong network of pharmaceutical companies and contract development and manufacturing organizations (CDMOs) that are expanding their production capacities to address the increasing demand for biologics, vaccines, and advanced therapeutic products. .

欧洲拥有多家领先的生物加工技术供应商，包括赛多利斯股份公司（Sartorius AG）和思拓凡（Cytiva），以及一个由制药公司和合同开发与生产组织（CDMOs）组成的强大网络，这些企业正在扩大其生产能力，以满足对生物制品、疫苗和先进治疗产品日益增长的需求。

Furthermore, supportive regulatory policies and a growing emphasis on sustainable manufacturing practices and continuous bioprocessing are accelerating the adoption of advanced processing equipment and high-performance consumables.

此外，支持性的监管政策以及对可持续制造实践和连续生物加工的日益重视，正在加速先进加工设备和高性能耗材的采用。

The availability of a highly skilled workforce, robust research and development capabilities, and the increasing outsourcing of biopharmaceutical manufacturing activities continue to strengthen the market's growth trajectory across the region.

高技能劳动力的供应、强大的研发能力，以及生物制药制造活动外包的日益增加，持续推动该地区市场的增长态势。

Asia-Pacific

亚太地区

The Asia Pacific region is becoming a key growth hub for the biopharmaceutical processing equipment and consumables market, driven by the rapid expansion of biopharmaceutical manufacturing, rising investments in biotechnology, and increasing demand for biologics and biosimilars.

在生物制药制造快速扩张、生物技术投资不断增加以及对生物制品和生物类似药需求日益增长的推动下，亚太地区正成为生物制药加工设备及耗材市场的关键增长中心。

Major economies, including China, India, South Korea, and Japan, are strengthening their domestic biopharmaceutical production capabilities through supportive government policies, favorable regulatory frameworks, and competitive manufacturing costs.

包括中国、印度、韩国和日本在内的主要经济体，正通过支持性政府政策、有利的监管框架以及具有竞争力的制造成本，加强其国内生物制药生产能力。

The growing presence of contract development and manufacturing organizations (CDMOs), coupled with increased clinical research activities and ongoing improvements in healthcare infrastructure, is fueling the need for advanced bioprocessing equipment and consumables.

合同开发与制造组织（CDMO）的日益壮大，加之临床研究活动的增加以及医疗保健基础设施的持续改善，正推动对先进生物加工设备和耗材的需求。

Furthermore, leading biopharmaceutical manufacturers such as Samsung Biologics and WuXi AppTec continue to invest in large-scale biologics production facilities across the region, enhancing manufacturing capacity, reinforcing supply chains, and driving the adoption of single-use technologies and next-generation bioprocessing solutions. .

此外，三星生物制剂和药明康德等领先的生物制药制造商持续在该地区投资大规模生物药生产设施，以提升生产能力、强化供应链，并推动一次性技术和新一代生物工艺解决方案的应用。

Collectively, these developments are establishing APAC as one of the fastest-growing and most strategically important markets in the global biopharmaceutical processing equipment and consumables industry.

总体而言，这些发展正使亚太地区成为全球生物制药工艺设备和耗材行业中增长最快、最具战略重要性的市场之一。

To know more about why North America is leading the market growth in the biopharmaceutical processing equipment & consumables market, get a snapshot of the

如需深入了解北美为何在生物制药加工设备与耗材市场增长中处于领先地位，请获取以下概览

Biopharmaceutical Processing Equipment & Consumables Market Share

生物制药加工设备与耗材市场份额

Recent Developmental Activities in the Biopharmaceutical Processing Equipment & Consumables Market

生物制药加工设备与耗材市场的近期发展动态

In

在

February 2026, Sartorius AG

2026年2月，赛多利斯股份公司

announced that it invested approximately EUR 442 million in expanding its bioprocess production capabilities, including facilities in Europe, with a focus on advanced filtration technologies and sustainable solutions.

宣布投资约4.42亿欧元，用于扩大其生物工艺生产能力，包括在欧洲的设施，重点发展先进过滤技术和可持续解决方案。

In

在

July 2025, Thermo Fisher Scientific

2025年7月，赛默飞世尔科技

acquired a manufacturing site from Sanofi to expand sterile fill-finish capacity, reflecting increasing demand for large-scale biologics production.

从赛诺菲收购了一处生产基地，以扩大无菌灌装产能，反映出对大规模生物制品生产的需求日益增长。

In

在

June 2025, Cytiva

2025年6月，Cytiva

expanded its filtration manufacturing capacity in Pensacola, Florida, increasing membrane production by 20% to meet rising demand for bioprocessing filters.

在佛罗里达州彭萨科拉扩大了其过滤制造能力，将膜产量提高了20%，以满足生物加工过滤器日益增长的需求。

In

在

June 2025, Cytiva

2025年6月，Cytiva

completed part of its $1.6 billion global investment program, including expansions in the United States to enhance bioprocessing manufacturing capabilities, reflecting strong regional demand for equipment and consumables.

完成了其16亿美元全球投资计划的一部分，包括在美国的扩张以增强生物加工制造能力，反映出该地区对设备和耗材的强劲需求。

In

在

June 2025, Cytiva

2025年6月，Cytiva

completed major capacity expansions, including significantly increasing chromatography resin production in Uppsala, Sweden, to strengthen regional supply chains and meet rising biologics demand.

完成了重大产能扩张，包括大幅增加瑞典乌普萨拉的色谱树脂产量，以加强区域供应链并满足日益增长的生物制品需求。

What is Biopharmaceutical Processing Equipment & Consumables?

什么是生物制药工艺设备与耗材？

Biopharmaceutical processing equipment and consumables comprise the specialized systems, instruments, and disposable products used throughout the manufacturing of biologic drugs, including monoclonal antibodies, vaccines, cell and gene therapies, recombinant proteins, and other biologics. Processing equipment includes bioreactors, fermenters, filtration systems, chromatography columns, centrifuges, mixers, incubators, and filling and finishing systems that enable upstream and downstream manufacturing operations.

生物制药加工设备和耗材包括在生物药（如单克隆抗体、疫苗、细胞与基因疗法、重组蛋白及其他生物制品）生产过程中使用的专用系统、仪器和一次性产品。加工设备涵盖生物反应器、发酵罐、过滤系统、层析柱、离心机、混合器、培养箱以及灌装和终装系统，这些设备支持上游和下游的生产操作。

Consumables encompass single-use bioprocessing products such as bioreactor bags, tubing, connectors, filters, membranes, culture media, chromatography resins, sampling devices, and sterile containers that come into direct contact with the product during production. Together, these technologies support efficient, scalable, and contamination-controlled manufacturing while ensuring compliance with stringent regulatory and quality standards.

耗材包括一次性生物工艺产品，例如生物反应器袋、管路、连接器、过滤器、膜、培养基、层析树脂、取样装置和无菌容器，这些产品在生产过程中与产品直接接触。这些技术共同支持高效、可扩展且受控污染的制造过程，同时确保符合严格的法规和质量标准。

The increasing adoption of single-use technologies, process automation, and continuous bioprocessing is further driving innovation in the biopharmaceutical processing equipment and consumables market..

一次性技术、流程自动化和连续生物加工的日益普及，正在进一步推动生物制药加工设备与耗材市场的创新。

Biopharmaceutical Processing Equipment & Consumables Market Report Metrics

生物制药加工设备与耗材市场报告指标

Details

详细信息

Coverage

覆盖范围

Global

全球

Study Period

学习周期

2023–2034

2023–2034

Biopharmaceutical Processing Equipment & Consumables Market CAGR

生物制药加工设备与耗材市场复合年增长率

~9%

约9%

Biopharmaceutical Processing Equipment & Consumables Market Size by 2034

2034年生物制药加工设备与耗材市场规模

USD 116.4 Billion

1164亿美元

Key Biopharmaceutical Processing Equipment & Consumables Companies

关键生物制药加工设备与耗材企业

Thermo Fisher Scientific Inc., Sartorius AG, Cytiva, Merck KGaA, Eppendorf SE, Lonza Group AG, Repligen Corporation, Avantor, Inc., Corning Incorporated, Danaher Corporation, Getinge AB, GEA Group AG, ABEC, Inc., PBS Biotech, Inc., Meissner Filtration Products, Inc., Entegris, Inc., Saint-Gobain Life Sciences, Parker-Hannifin Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and others.

赛默飞世尔科技公司、 Sartorius AG、 Cytiva、 Merck KGaA、 Eppendorf SE、 Lonza Group AG、 Repligen Corporation、 Avantor, Inc.、 Corning Incorporated、 Danaher Corporation、 Getinge AB、 GEA Group AG、 ABEC, Inc.、 PBS Biotech, Inc.、 Meissner Filtration Products, Inc.、 Entegris, Inc.、 Saint-Gobain Life Sciences、 Parker-Hannifin Corporation、 Agilent Technologies, Inc.、 Bio-Rad Laboratories, Inc.，以及其他公司。

Biopharmaceutical Processing Equipment & Consumables Market Assessment

生物制药加工设备与耗材市场评估

Biopharmaceutical Processing Equipment & Consumables Market Segmentation

生物制药加工设备与耗材市场细分

Biopharmaceutical Processing Equipment & Consumables Market Segmentation By Product Type:

生物制药加工设备与耗材市场按产品类型细分：

Equipment (Bioreactors, Filtration Systems, Chromatography Systems, Centrifuges & Separators, and Others) and Consumables

设备（生物反应器、过滤系统、色谱系统、离心机与分离器及其他）和耗材

Biopharmaceutical Processing Equipment & Consumables Market Segmentation By Workflow Stage:

生物制药加工设备与耗材市场按工作流程阶段细分：

Upstream Processing, Downstream Processing, Formulation & Fill-Finish, and Quality Control & Analytical Testing

上游工艺、下游工艺、制剂与灌装封口，以及质量控制与分析检测

Biopharmaceutical Processing Equipment & Consumables Market Segmentation By Application:

按应用划分的生物制药加工设备及耗材市场细分：

Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell & Gene Therapies, and Others

单克隆抗体（mAbs）、疫苗、重组蛋白、细胞与基因疗法及其他

Biopharmaceutical Processing Equipment & Consumables Market Segmentation By Geography

按地理划分的生物制药加工设备及耗材市场细分

: North America, Europe, Asia-Pacific, and Rest of World

：北美、欧洲、亚太地区及世界其他地区

Porter's Five Forces Analysis, Product Profiles,

波特五力分析、产品概况，

Case Studies, KOL

案例研究，关键意见领袖

'

'

s Views, Analyst

分析师观点

'

'

s View

s 视图

Which MedTech key players in the biopharmaceutical processing equipment & consumables market are set to emerge as the trendsetter explore @

在生物制药加工设备和耗材市场中，哪些医疗科技关键企业将成为趋势引领者？探索 @

Biopharmaceutical Processing Equipment & Consumables Market Analysis

生物制药加工设备与耗材市场分析

Table of Contents

目录

1

1

Biopharmaceutical Processing Equipment & Consumables Market Report Introduction

生物制药加工设备与耗材市场报告简介

2

2

Biopharmaceutical Processing Equipment & Consumables Market Executive Summary

生物制药加工设备与耗材市场执行摘要

3

3

Biopharmaceutical Processing Equipment & Consumables Market Key Factors Analysis

生物制药加工设备与耗材市场关键因素分析

4

4

Impact Analysis

影响分析

5

5

Regulatory Analysis

监管分析

6

6

Biopharmaceutical Processing Equipment & Consumables Market Porter's Five Forces Analysis

生物制药加工设备与耗材市场波特五力分析

7

7

Biopharmaceutical Processing Equipment & Consumables Market Assessment

生物制药加工设备与耗材市场评估

8

8

Competitive Landscape

竞争格局

9

9

Startup Funding & Investment Trends

初创企业融资与投资趋势

10

10

Biopharmaceutical Processing Equipment & Consumables Market Company and Product Profiles

生物制药加工设备与耗材市场公司及产品概况

11

十一

KOL Views

KOL 观点

12

十二

Project Approach

项目方法

13

13

About DelveInsight

关于 DelveInsight

14

14

Disclaimer & Contact Us

免责声明 & 联系我们

Interested in knowing the biopharmaceutical processing equipment & consumables market share by 2034? Click to get a snapshot of the

想了解2034年生物制药加工设备及耗材的市场份额吗？点击获取概览

Biopharmaceutical Processing Equipment & Consumables Market Size

生物制药加工设备与耗材市场规模

Related Reports

相关报告

Single-use Bioreactors

一次性生物反应器

Market

市场

Single-use Bioreactors

一次性生物反应器

Market Insights, Competitive Landscape, and Market Forecast – 2034

市场洞察、竞争格局与市场预测——2034年

report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key single-use bioreactors companies, including

报告提供对市场趋势、市场驱动因素、市场壁垒以及关键一次性生物反应器公司的深入理解，包括

Sartorius AG, Thermo Fisher Scientific Inc., Cytiva, Merck KGaA, Eppendorf SE, ABEC Inc., PBS Biotech Inc., Cellexus International Ltd., Celltainer Biotech BV, Getinge AB, Solaris Biotech Solutions S.r.l., Pierre Guérin SAS, Meissner Filtration Products Inc., Entegris Inc., Avantor Inc., Repligen Corporation, Corning Incorporated.

赛多利斯股份公司、赛默飞世尔科技公司、Cytiva、默克集团、艾本德股份公司、ABEC公司、PBS生物科技公司、Cellexus国际有限公司、Celltainer生物技术公司、捷温集团、Solaris生物技术解决方案有限公司、皮埃尔·盖兰公司、迈斯纳过滤产品公司、英特格公司、阿凡托公司、雷普利根公司、康宁公司。

,

，

and others.

以及其他。

Pharmaceutical Filtration Market

制药过滤市场

Pharmaceutical Filtration Market Insight, Competitive Landscape, and Market Forecast – 2034

制药过滤市场洞察、竞争格局及市场预测——2034年

report delivers an in-depth understanding of market trends, market drivers, market barriers, and key pharmaceutical filtration companies, including

报告深入剖析了市场趋势、市场驱动因素、市场壁垒以及主要的制药过滤公司，包括

Sartorius AG, Merck KGaA (MilliporeSigma), Pall Corporation, Thermo Fisher Scientific Inc., 3M Company, Meissner Filtration Products, Inc., Porvair Filtration Group Ltd., Donaldson Company, Inc., GVS S.p.A., Eaton Corporation plc, Parker-Hannifin Corporation, Saint-Gobain Life Sciences, Amazon Filters Ltd., Cobetter Filtration Equipment Co., Ltd., Repligen Corporation, GEA Group Aktiengesellschaft, Alfa Laval AB, Asahi Kasei Corporation, Koch Separation Solutions, Sterlitech Corporation.

赛多利斯股份公司、默克集团（MilliporeSigma）、颇尔公司、赛默飞世尔科技公司、3M公司、Meissner Filtration Products, Inc.、Porvair Filtration Group Ltd.、唐纳森公司、GVS S.p.A.、伊顿公共有限公司、派克汉尼汾公司、圣戈班生命科学部门、Amazon Filters Ltd.、科百特过滤器材有限公司、Repligen Corporation、GEA 集团股份公司、阿法拉伐公司、旭化成株式会社、Koch Separation Solutions、Sterlitech Corporation。

,

，

and others.

以及其他。

Upstream Processing Market

上游处理市场

Upstream Processing Market Insight, Competitive Landscape, and Market Forecast – 2034

上游加工市场洞察、竞争格局及市场预测——2034年

report delivers an in-depth understanding of market trends, market drivers, market barriers, and key upstream processing companies, including

报告深入剖析了市场趋势、市场驱动因素、市场壁垒以及关键上游加工企业，包括

Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Eppendorf SE, Lonza Group AG, Corning Incorporated, Avantor, Inc., Getinge AB, Repligen Corporation, FUJIFILM Irvine Scientific, Inc., PBS Biotech, Inc., Hamilton Company, Entegris, Inc., Meissner Filtration Products, Inc., Applikon Biotechnology B.V., Kühner AG, Cellexus International Ltd., GE HealthCare Technologies Inc., AGC Biologics.

赛默飞世尔科技公司、 Sartorius AG、 Merck KGaA、 丹纳赫公司、 Eppendorf SE、 Lonza Group AG、 康宁公司、 Avantor, Inc.、 Getinge AB、 Repligen Corporation、 FUJIFILM Irvine Scientific, Inc.、 PBS Biotech, Inc.、 Hamilton Company、 Entegris, Inc.、 Meissner Filtration Products, Inc.、 Applikon Biotechnology B.V.、 Kühner AG、 Cellexus International Ltd.、 GE HealthCare Technologies Inc.、 AGC Biologics。

,

，

and others.

以及其他。

Downstream Processing Market

下游加工市场

Downstream Processing Market Insight, Competitive Landscape, and Market Forecast – 2034

下游加工市场洞察、竞争格局及市场预测 – 2034年

report delivers an in-depth understanding of market trends, market drivers, market barriers, and key downstream processing companies, including

报告深入剖析了市场趋势、市场驱动因素、市场壁垒以及关键下游加工企业，包括

Thermo Fisher Scientific, Merck KGaA, Danaher Corporation (Cytiva), Sartorius AG, Lonza

赛默飞世尔科技、默克集团（Merck KGaA）、丹纳赫公司（Cytiva）、 Sartorius AG、龙沙集团

,

，

and others.

以及其他。

About

关于

DelveInsight

DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

DelveInsight 是一家领先的商业咨询和市场研究公司，专注于生命科学领域。它通过提供全面的端到端解决方案来支持制药公司提升其绩效。通过我们基于订阅的平台 PharmDelve，您可以轻松获取所有医疗保健和制药市场研究报告。

.

。

Contact Us

联系我们

Shruti Thakur

什鲁蒂·塔库尔

[email protected]

[email protected]

+14699457679

+14699457679

SOURCE DelveInsight Business Research, LLP

来源：DelveInsight Business Research, LLP

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

请求演示